These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

395 related items for PubMed ID: 8220885

  • 1. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277.
    Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M.
    Br J Pharmacol; 1993 Sep; 110(1):245-52. PubMed ID: 8220885
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.
    Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J.
    Br J Pharmacol; 1993 Oct; 110(2):761-71. PubMed ID: 8242249
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo characterization of the activity of telmisartan: an insurmountable angiotensin II receptor antagonist.
    Maillard MP, Perregaux C, Centeno C, Stangier J, Wienen W, Brunner HR, Burnier M.
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1089-95. PubMed ID: 12183667
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological characterization of KR-30988, a novel non-peptide AT1 receptor antagonist, in rat, rabbit and dog.
    Lee BH, Lee SH, Jung YS, Seo HW, Yoo SE, Shin HS.
    J Pharm Pharmacol; 1999 Oct; 51(10):1191-200. PubMed ID: 10579691
    [Abstract] [Full Text] [Related]

  • 9. In vivo pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Cazes M, Provost D, Versigny A, Cloarec A.
    Eur J Pharmacol; 1995 Sep 15; 284(1-2):157-70. PubMed ID: 8549620
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological properties of KT3-671, a novel nonpeptide angiotensin II receptor antagonist.
    Mochizuki S, Sato T, Furuta K, Hase K, Ohkura Y, Fukai C, Kosakai K, Wakabayashi S, Tomiyama A.
    J Cardiovasc Pharmacol; 1995 Jan 15; 25(1):22-9. PubMed ID: 7723348
    [Abstract] [Full Text] [Related]

  • 11. Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116).
    Shibouta Y, Inada Y, Ojima M, Wada T, Noda M, Sanada T, Kubo K, Kohara Y, Naka T, Nishikawa K.
    J Pharmacol Exp Ther; 1993 Jul 15; 266(1):114-20. PubMed ID: 8331552
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.
    Wienen W, Mauz AB, Van Meel JC, Entzeroth M.
    Mol Pharmacol; 1992 Jun 15; 41(6):1081-8. PubMed ID: 1614410
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats.
    van Meel JC, Redemann N, Haigh RM.
    Arzneimittelforschung; 1996 Aug 15; 46(8):755-9. PubMed ID: 9125273
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA.
    J Hypertens; 2001 Mar 15; 19(3):465-73. PubMed ID: 11288817
    [Abstract] [Full Text] [Related]

  • 18. In vitro pharmacological characterization of UP 269-6, a novel nonpeptide angiotensin II receptor antagonist.
    Caussade F, Virone-Oddos A, Delchambre C, Cazes M, Versigny A, Cloarec A.
    Fundam Clin Pharmacol; 1995 Mar 15; 9(2):119-28. PubMed ID: 7628824
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.